|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Bioaxone 
|
|
BioAxone Therapeutic, a neuroscience company, is developing an experimental therapy for the treatment of neurological disorders. Our lead drug, Cethrin, is in clinical trial for spinal cord injury throughout Canada and the United States. The modified C3 exoenzyme provides neuroprotection and neuroregeneration by inhibiting Rho GTPase signaling.
Activity:
- Research & Development
Product / Technology type(s) covered:
- Bio
- Pharmaceuticals / Therapeutics
Therapeutic targets:
- Neurology
|
|
Company Contact
|
Bioaxone
7150 rue Frederick-Banting, Suite 200
H4S 2A1 Saint-Laurent
Quebec
Canada
Phone: (514) 282-9990
FAX: (514) 282-9990
Website: http://www.bioaxone.com
Send an email
|
|
Markets Covered
a. HeadQuarter: Canada
b. Continent(s) active:
North America
, Europe
c. Countries active: USA, CANADA, GERMANY, FRANCE
Corporate data:
Number of Employees: 10
Turnover:
| Amount: |
Year: |
Currency: |
| 0 |
2005 |
US Dollar |
Year founded: 2000
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: 12-Oct-2006.
|
Add
Company
Subscribe
Search
Contact
